<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ballard PL</submitter><funding>NHLBI NIH HHS</funding><pagination>305-311</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6377352</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>85(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Many premature infants with respiratory failure are deficient in surfactant, but the relationship to occurrence of bronchopulmonary dysplasia (BPD) is uncertain.&lt;h4>Methods&lt;/h4>Tracheal aspirates were collected from 209 treated and control infants enrolled at 7-14 days in the Trial of Late Surfactant. The content of phospholipid, surfactant protein B, and total protein were determined in large aggregate (active) surfactant.&lt;h4>Results&lt;/h4>At 24 h, surfactant treatment transiently increased surfactant protein B content (70%, p &lt; 0.01), but did not affect recovered airway surfactant or total protein/phospholipid. The level of recovered surfactant during dosing was directly associated with content of surfactant protein B (r = 0.50, p &lt; 0.00001) and inversely related to tota</pubmed_abstract><journal>Pediatric research</journal><pubmed_title>Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment.</pubmed_title><pmcid>PMC6377352</pmcid><funding_grant_id>U01 HL101798</funding_grant_id><funding_grant_id>U01 HL094338</funding_grant_id><funding_grant_id>U01 HL094355</funding_grant_id><pubmed_authors>Keller RL</pubmed_authors><pubmed_authors>Truog WE</pubmed_authors><pubmed_authors>Chapin C</pubmed_authors><pubmed_authors>Segal MR</pubmed_authors><pubmed_authors>Ballard RA</pubmed_authors><pubmed_authors>Horneman H</pubmed_authors><pubmed_authors>Ballard PL</pubmed_authors><pubmed_authors>Tolsurf Investigators</pubmed_authors></additional><is_claimable>false</is_claimable><name>Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment.</name><description>&lt;h4>Background&lt;/h4>Many premature infants with respiratory failure are deficient in surfactant, but the relationship to occurrence of bronchopulmonary dysplasia (BPD) is uncertain.&lt;h4>Methods&lt;/h4>Tracheal aspirates were collected from 209 treated and control infants enrolled at 7-14 days in the Trial of Late Surfactant. The content of phospholipid, surfactant protein B, and total protein were determined in large aggregate (active) surfactant.&lt;h4>Results&lt;/h4>At 24 h, surfactant treatment transiently increased surfactant protein B content (70%, p &lt; 0.01), but did not affect recovered airway surfactant or total protein/phospholipid. The level of recovered surfactant during dosing was directly associated with content of surfactant protein B (r = 0.50, p &lt; 0.00001) and inversely related to tota</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2025-04-18T17:55:54.571Z</modification><creation>2019-03-26T22:55:53Z</creation></dates><accession>S-EPMC6377352</accession><cross_references><pubmed>30140069</pubmed><doi>10.1038/s41390-018-0144-3</doi></cross_references></HashMap>